Laura Creevey
Overview
Explore the profile of Laura Creevey including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
4
Citations
81
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Creevey L, Bleach R, Madden S, Toomey S, Bane F, Vareslija D, et al.
Mol Cancer Ther
. 2019 Jul;
18(10):1731-1743.
PMID: 31289138
Divergent roles for androgen receptor (AR) in breast cancer have been reported. Following aromatase inhibitor (AI) treatment, the conversion of circulating androgens into estrogens can be diminished by >99%. We...
2.
Ali A, Creevey L, Hao Y, McCartan D, OGaora P, Hill A, et al.
Breast Cancer Res
. 2015 Sep;
17:123.
PMID: 26341737
Introduction: HOX genes play vital roles in growth and development, however, atypical redeployment of these genes is often associated with steroidal adaptability in endocrine cancers. We previously identified HOXC11 to...
3.
Harvey H, Piskareva O, Creevey L, Alcock L, Buckley P, OSullivan M, et al.
Int J Cancer
. 2014 Aug;
136(7):1579-88.
PMID: 25137037
The acquisition of multidrug resistance is a major impediment to the successful treatment of neuroblastoma, a clinically heterogeneous cancer accounting for ∼15% of all pediatric cancer deaths. The MYCN transcription...
4.
Creevey L, Ryan J, Harvey H, Bray I, Meehan M, Khan A, et al.
Mol Cancer
. 2013 Mar;
12:23.
PMID: 23531080
Background: Neuroblastoma is responsible for 15% of all childhood cancer deaths. Despite advances in treatment and disease management, the overall 5-year survival rates remain poor in high-risk disease (25-40%). MiR-497...